- Report
- February 2023
- 250 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- June 2023
- 298 Pages
Global
From €4898EUR$4,950USD£4,247GBP
- Report
- July 2023
- 70 Pages
Global
From €5887EUR$5,950USD£5,105GBP
- Report
- October 2023
- 193 Pages
Global
From €5541EUR$5,600USD£4,805GBP
- Report
- May 2023
- 148 Pages
Global
From €3957EUR$3,999USD£3,431GBP
- Report
- February 2023
- 217 Pages
Global
From €4502EUR$4,550USD£3,904GBP
- Report
- November 2022
- 120 Pages
Global
From €2474EUR$2,500USD£2,145GBP
- Report
- April 2023
- 147 Pages
Global
From €5935EUR$5,999USD£5,147GBP
- Report
- January 2023
- 28 Pages
Global
From €1336EUR$1,350USD£1,158GBP
- Report
- October 2022
- 127 Pages
Global
From €3958EUR$4,000USD£3,432GBP
- Report
- June 2023
- 72 Pages
United States
From €1237EUR$1,250USD£1,073GBP
- Report
- March 2023
- 350 Pages
Europe
From €2670EUR$2,699USD£2,316GBP
- Report
- August 2023
- 205 Pages
Europe
From €2968EUR$3,000USD£2,574GBP
- Report
- June 2023
- 150 Pages
Global
From €3953EUR$3,995USD£3,428GBP
- Report
- January 2023
- 306 Pages
Global
From €4156EUR$4,200USD£3,604GBP
- Report
- September 2023
- 175 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- August 2023
- 175 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- August 2023
- 175 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- May 2023
- 250 Pages
Global
From €4947EUR$5,000USD£4,290GBP
- Report
- February 2023
- 250 Pages
Global
From €4947EUR$5,000USD£4,290GBP

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers.
Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more